Searching the Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Central noradrenergic (NA) neurons are key constituents of the respiratory homeostatic network. NA dysfunction is implicated in several developmental respiratory disorders including Congenital Central Hyperventilation Syndrome (CCHS), Sudden Infant Death Syndrome (SIDS) and Rett Syndrome. The current unchallenged paradigm in the field, supported by multiple studies, is that glutamate co-transmission in subsets of central NA neurons plays a role in breathing control. If true, NA-glutamate co-transmission may also be mechanistically important in respiratory disorders. However, the requirement of NA-derived glutamate in breathing has not been directly tested and the extent of glutamate co-transmission in the central NA system remains uncharacterized. Therefore, we fully characterized the cumulative fate maps and acute adult expression patterns of all three Vesicular Glutamate Transporters (Slc17a7 (Vglut1), Slc17a6 (Vglut2), and Slc17a8 (Vglut3)) in NA neurons, identifying a novel, dynamic expression pattern for Vglut2 and an undescribed co-expression domain for Vglut3 in the NA system. In contrast to our initial hypothesis that NA derived glutamate is required to breathing, our functional studies showed that loss of Vglut2 throughout the NA system failed to alter breathing or metabolism under room air, hypercapnia, or hypoxia in unrestrained and unanesthetized mice. These data demonstrate that Vglut2-based glutamatergic signaling within the central NA system is not required for normal baseline breathing and hypercapnic, hypoxic chemosensory reflexes. These outcomes challenge the current understanding of central NA neurons in the control of breathing and suggests that glutamate may not be a critical target to understand NA neuron dysfunction in respiratory diseases.
Pubmed ID: 37090585
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Mus musculus with name B6.Cg-Gt(ROSA)26Sortm1.3(CAG-tdTomato.-EGFP)Pjen/J from IMSR.
View all literature mentionsMus musculus with name STOCK Tg(Slc17a8-icre)1Edw/SealJ from IMSR.
View all literature mentionsMus musculus with name B6.129S7(FVB)-Dbhem2.1(flpo)Rray/Mmucd from MMRRC.
View all literature mentionsMus musculus with name B6.FVB(Cg)-Tg(Dbh-cre)KH212Gsat/Mmucd from MMRRC.
View all literature mentionsMus musculus with name B6;129S-Slc17a7tm1.1(cre)Hze/J from IMSR.
View all literature mentionsMus musculus with name STOCK Slc17a6tm2(cre)Lowl/J from IMSR.
View all literature mentionsMus musculus with name B6.129S7(FVB)-Dbhem2.1(flpo)Rray/Mmucd from MMRRC.
View all literature mentionsMus musculus with name STOCK Slc17a6tm1Lowl/J from IMSR.
View all literature mentions